Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Uncharacterized protein KIAA0930 is a cytosolic protein encoded by the KIAA0930 gene on chromosome 22 (22q13.31), without any established domains or signaling motifs[1][3][4]. It contains a domain of unknown function (DUF2045). Disease associations include Acheiropody and Cranioectodermal dysplasia 1, and it has been implicated in some cancer-associated gene fusions (e.g., KIAA0930-SMC1B), but its biological function remains unclear, and it is not currently recognized as a therapeutic target or a receptor, enzyme, transporter, or transcription factor[1][3][4][5]. KIAA0930 is localized in the cytosol and is not a secreted protein[4]. Protein interaction data suggest weak or indirect association with various cell signaling adapter proteins, but a specific role has not been verified[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uncharacterized protein KIAA0930 (KIAA0930).